These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12911539)

  • 21. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase.
    Odobasic D; Muljadi RC; O'Sullivan KM; Kettle AJ; Dickerhof N; Summers SA; Kitching AR; Holdsworth SR
    Arthritis Rheumatol; 2015 Jul; 67(7):1868-80. PubMed ID: 25777776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
    Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
    Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
    Xiang L; Liu A; Xu G
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pristane-induced autoimmunity in germ-free mice.
    Mizutani A; Shaheen VM; Yoshida H; Akaogi J; Kuroda Y; Nacionales DC; Yamasaki Y; Hirakata M; Ono N; Reeves WH; Satoh M
    Clin Immunol; 2005 Feb; 114(2):110-8. PubMed ID: 15639644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis.
    Dos Santos M; Poletti PT; Favero G; Stacchiotti A; Bonomini F; Montanari CC; Bona SR; Marroni NP; Rezzani R; Veronese FV
    Autoimmunity; 2018 Mar; 51(2):69-80. PubMed ID: 29480020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
    Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
    Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing progression of experimental lupus nephritis via inhibition of the B7/CD28 signaling pathway.
    Huang L; Kong Y; Wang J; Sun J; Shi Q; Qiu YH
    Mol Med Rep; 2015 Sep; 12(3):4187-4195. PubMed ID: 26096149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
    Xu Y; Lee PY; Li Y; Liu C; Zhuang H; Han S; Nacionales DC; Weinstein J; Mathews CE; Moldawer LL; Li SW; Satoh M; Yang LJ; Reeves WH
    J Immunol; 2012 Apr; 188(8):4113-21. PubMed ID: 22422888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models.
    Guo Q; Zhang L; Yaron JR; Burgin M; Schutz LN; Awo EA; Lucas AR
    Methods Mol Biol; 2021; 2225():241-255. PubMed ID: 33108667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
    Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
    Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.
    Liu X; Jiao Y; Cui B; Gao X; Xu J; Zhao Y
    Lupus; 2016 Oct; 25(11):1180-9. PubMed ID: 27125291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-17 promotes murine lupus.
    Amarilyo G; Lourenço EV; Shi FD; La Cava A
    J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
    Satoh M; Kumar A; Kanwar YS; Reeves WH
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10934-8. PubMed ID: 7479913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation.
    Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
    Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model.
    Dos Santos M; Favero G; Bonomini F; Stacchiotti A; Rodella LF; Veronese FV; Rezzani R
    Life Sci; 2018 Jan; 193():242-251. PubMed ID: 29097157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.